U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07560735) titled 'Clinical Evaluation of Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease Using In Vivo Confocal Microscopy' on April 17.
Brief Summary: This is a single center, open label trial to evaluate Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease using In Vivo Confocal Microscopy (IVCM
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Dry Eye
Intervention:
DRUG: Lifitegrast Ophthalmic Solution 5.0% (Xiidra)
30 subjects with DED will receive lifitegrast ophthalmic solution 5.0% (Xiidra)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Toyos Clinic
Published by HT Digital Content Services with permission ...